Lipid Biomarkers for Diabetic Heart Disease

Completed · Not applicable · Has a placebo group

Conditions studied: Type II Diabetes Mellitus, Diabetes Complications

In brief

This study will test whether lowering the delivery of excess fats to the heart in persons with type-2 diabetes mellitus improves heart muscle function. The investigators will also test whether specific lipid molecular species in plasma can serve as biomarkers for diabetic heart disease.

Key facts

Study ID

NCT01752842

Run by

Washington University School of Medicine

People needed

70

Starts

2013-03-01

Expected to finish

2018-02-23

Last updated by the study team

2019-03-15

Who can join

Age: 30 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes mellitus

You may not qualify if…

• body weight > 300 lb.
• HIV
• hypothyroid
• steroid medication, fenofibrate
• smoking
• BP > 140/90
• heart disease
• pregnant or lactating
• consumption of > 5 alcoholic drinks/wk
• creatinine > 1.5 mg/dL
• hematocrit < 28

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.